ArticleThe Journal of investigative dermatology2021

Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma.

Chao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.